Concepedia

Soraya Madani

SM

6

Publications

1.4K

Citations

6

H-Index

1999

Active since

Affiliations

University of Alabama at Birmingham(Current)

University of California, San Francisco

Charité - Universitätsmedizin Berlin

Mayo Clinic in Arizona

Heinrich Heine University Düsseldorf

Soraya Madani is an author at University of Alabama at Birmingham specializing in ophthalmology, neuroimmunology, and neurology.

Top concepts

Publications per year

1999–2019

6

Publications

6

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim et al. · The Lancet · 2019 · 679 citations

, , +5

Evaluation of Cytochrome P450 Probe Substrates Commonly Used by the Pharmaceutical Industry to Study in Vitro Drug Interactions

Rae Yuan, Soraya Madani, Xiaoxiong Wei et al. · Drug Metabolism and Disposition · 2002 · 323 citations

Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study

Mark Agius, Gabriela Kłodowska-Duda, Maciej Maciejowski et al. · Multiple Sclerosis Journal · 2017 · 137 citations · Full text

Comparison of CYP2D6 Content and Metoprolol Oxidation Between Microsomes Isolated from Human Livers and Small Intestines

Soraya Madani, Mary F. Paine, Lydia Lewis et al. · Pharmaceutical Research · 1999 · 86 citations

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations

Bruce Cree, Jeffrey L. Bennett, Mark Sheehan et al. · Multiple Sclerosis Journal · 2015 · 71 citations · Full text

Rows per page

1–5 of 6